DEF-3(g16/NY-LU-12), an RNA binding protein from the 3p21.3 homozygous deletion region in SCLC

被引:40
作者
Drabkin, HA
West, JD
Hotfilder, M
Heng, YM
Erickson, P
Calvo, R
Dalmau, J
Gemmill, RM
Sablitzky, F
机构
[1] Univ Colorado, Hlth Sci Ctr, Div Med Oncol, Denver, CO 80262 USA
[2] Univ Hosp Munster, Dept Expt Neurooncol, Munster, Germany
[3] UCL, Windeyer Inst Med Sci, Dept Med, London, England
[4] Hosp Badalona Germans Trias & Pujol, Dept Med, Barcelona, Spain
[5] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA
[6] Mem Sloan Kettering Canc Ctr, Mol Neurooncol Lab, New York, NY 10021 USA
基金
英国惠康基金;
关键词
granulocyte differentiation; zinc finger; POZ domain;
D O I
10.1038/sj.onc.1202601
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
DEF-3(g16/NY-LU-12) encodes a novel RNA binding protein isolated by positional cloning from an SCLC homozygous deletion region in 3p21.3 and, in parallel, as a differentially expressed gene during myelopoiesis from FDCPmix-A4 cells, DEF-3(g16/NY-LU-12) is ubiquitously expressed during mouse embryogenesis and in adult organs while human hematopoietic tissues showed differential expression, The mouse and human proteins are highly conserved containing two RNA recognition motifs (RRMs) and other domains associated with RNA binding and protein-protein interactions. A database search identified related proteins in human, rat, C. elegans and S, pombe including the 3p21.3 co-deleted gene, LUCA15, Recombinant proteins containing the RRMs of DEF-3(g16/NY-LU-12) and LUCA15 specifically bound poly(G) RNA homopolymers in vitro. These RRMs also show similarity to those of the Hu protein family. Since anti-Hu RRM domain antibodies are associated with an anti-tumor effect and paraneoplastic encephalomyelitis, we tested sera from Hu syndrome patients with the RRMs of DEF-3(g16/NY-LU-12) and LUCA15, These were non-reactive. Thus, DEF-3(g16/NY-LU-12) and LUCA15 represent members of a novel family of RNA binding proteins with similar expression patterns and in vitro RNA binding characteristics. They are co-deleted in some lung cancers and immunologically distinct from the Hu proteins.
引用
收藏
页码:2589 / 2597
页数:9
相关论文
共 30 条
[1]   ACCELERATION OF NUCLEIC-ACID HYBRIDIZATION RATE BY POLYETHYLENE-GLYCOL [J].
AMASINO, RM .
ANALYTICAL BIOCHEMISTRY, 1986, 152 (02) :304-307
[2]   THE POZ DOMAIN - A CONSERVED PROTEIN-PROTEIN INTERACTION MOTIF [J].
BARDWELL, VJ ;
TREISMAN, R .
GENES & DEVELOPMENT, 1994, 8 (14) :1664-1677
[3]   ANALYSIS OF THE RNA-RECOGNITION MOTIF AND RS AND RGG DOMAINS - CONSERVATION IN METAZOAN PRE-MESSENGER-RNA SPLICING FACTORS [J].
BIRNEY, E ;
KUMAR, S ;
KRAINER, AR .
NUCLEIC ACIDS RESEARCH, 1993, 21 (25) :5803-5816
[4]   CONSERVED STRUCTURES AND DIVERSITY OF FUNCTIONS OF RNA-BINDING PROTEINS [J].
BURD, CG ;
DREYFUSS, G .
SCIENCE, 1994, 265 (5172) :615-621
[5]  
Cairns P, 1997, CANCER RES, V57, P5356
[6]   ANTI-HU-ASSOCIATED PARANEOPLASTIC ENCEPHALOMYELITIS SENSORY NEURONOPATHY - A CLINICAL-STUDY OF 71 PATIENTS [J].
DALMAU, J ;
GRAUS, F ;
ROSENBLUM, MK ;
POSNER, JB .
MEDICINE, 1992, 71 (02) :59-72
[7]  
DALY MC, 1993, ONCOGENE, V8, P1721
[8]   Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger retinoic acid receptor alpha fusion protein [J].
Dong, S ;
Zhu, J ;
Reid, A ;
Strutt, P ;
Guidez, F ;
Zhong, HJ ;
Wang, ZY ;
Licht, J ;
Waxman, S ;
Chomienne, C ;
Chen, Z ;
Zelent, A ;
Chen, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (08) :3624-3629
[9]   SELECTION OF A SUBSET OF MESSENGER-RNAS FROM COMBINATORIAL 3' UNTRANSLATED REGION LIBRARIES USING NEURONAL RNA-BINDING PROTEIN HEL-N1 [J].
GAO, FB ;
CARSON, CC ;
LEVINE, T ;
KEENE, JD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (23) :11207-11211
[10]   Anti-Hu antibodies in patients with small-cell lung cancer: Association with complete response to therapy and improved survival [J].
Graus, F ;
Dalmau, J ;
Rene, R ;
Tora, M ;
Malats, N ;
Verschuuren, JJ ;
Cardenal, F ;
Vinolas, N ;
delMuro, JG ;
Vadell, C ;
Mason, WP ;
Rosell, R ;
Posner, JB ;
Real, FX .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (08) :2866-2872